MedTrace Logo

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

NCT00003186 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2013-02-05

No results posted yet for this study

Summary

RATIONALE: Diagnostic procedures, such as lymphography, may improve the identification of patients with metastatic colorectal cancer.

PURPOSE: Clinical trial to study the effectiveness of lymphography in determining the presence or absence of metastatic colorectal cancer in patients.

Conditions

Interventions

DRUG

isosulfan blue

PROCEDURE

lymphangiography

PROCEDURE

sentinel lymph node biopsy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Miguel A. Rodriguez-Bigas, MD · M.D. Anderson Cancer Center

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-04-30
Primary Completion
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00003186 on ClinicalTrials.gov